CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.
For the period ended Jun 30, 2026. Filed Aug 7, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2026 · Filed Aug 7, 2026
CELZ$0.62+2.6%Stored close · as of Nov 6, 2026
Contents
Unaudited Condensed Consolidated Balance Sheets
| June 30, 2026 | December 31, 2025 | |
|---|---|---|
| ASSETS | ||
| CURRENT ASSETS | ||
| Cash | $8,714,115 | $7,208,126 |
| Investments in related entity | 125,000 | - |
| Note receivable, net of premium | 109,338 | 52,084 |
| Prepaids and other current assets | 70,460 | 138,804 |
| Total Current Assets | 9,018,913 | 7,399,014 |
| OTHER ASSETS | ||
| Other assets | 3,281 | 3,281 |
| Licenses, net of amortization | 355,459 | 407,230 |
| TOTAL ASSETS | $9,377,653 | $7,809,525 |
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||
| CURRENT LIABILITIES | ||
| Accounts payable | $684,401 | $270,686 |
| Advances from related party | 14,194 | 14,194 |
| Total Current Liabilities | 698,595 | 284,880 |
| TOTAL LIABILITIES | 698,595 | 284,880 |
| STOCKHOLDERS' EQUITY | ||
| Preferred stock, $0.001 par value, 10,000,000 shares authorized at June 30, 2026 and December 31, 2025 | - | - |
| Common stock, $0.001 par value, 25,000,000 shares authorized; 6,497,008 and 3,701,668 issued; 6,492,008 and 3,696,668 outstanding at June 30, 2026 and December 31, 2025, respectively | 6,491 | 3,144 |
| Additional paid-in capital | 82,162,455 | 78,108,422 |
| Accumulated deficit | (73,503,974) | (70,586,921) |
| Treasury stock, at cost, 5,000 shares as of June 30, 2026 and December 31, 2025 | (10,000) | (10,000) |
| TOTAL STOCKHOLDERS' EQUITY | 8,654,972 | 7,514,645 |
| Non-controlling interest | 24,086 | 10,000 |
| TOTAL EQUITY ATTRIBUTABLE TO CMTH | 8,679,058 | 7,524,645 |
| TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY | $9,377,653 | $7,809,525 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.